Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects
Recruitment status was Not yet recruiting
The study will find out how effective rupatadine is in the treatment of mosquito bite symptoms in adult patients allergic to mosquito bites.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Primary Purpose: Prevention
|Official Title:||A Placebo-Controlled, Double-Blind, Cross-Over Study With Rupatadine 10 Mg in 30 Mosquito-Bite Allergic Adult Subjects|
- Bite lesion size (squared mm)
- Pruritus on a Visual Analog Scale
Mosquito-bite symptoms include wheals and pruritic bite papules. Oral antihistamines have shown to decrease whealing ang accompanying pruritus in placebo-controlled trials.
Subjects will be treated for 4 days, and exposed to experimental mosquito bite at day 3.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00258141
|Contact: Timo Reunala, Prof.||(+358) firstname.lastname@example.org|
|Ulappatorin Lääkäriasema||Not yet recruiting|
|Principal Investigator: Leena Ackermann, MD|
|Koskiklinikka, Tampere Lääkärikeskus||Not yet recruiting|
|Tampere, Finland, 33101|
|Principal Investigator: Ari Karppinen, MD|
|Principal Investigator:||Timo Reunala, Prof.||Medical School, University of Tampere and Tampere University Hospital|